NAC Attack: A Phase-3, Multicenter, Randomized, Placebo-Controlled Trial in Patients with Retinitis Pigmentosa

Project: Research project

Project Details

Description

NAC Attack: A Phase-3, Multicenter, Randomized, Placebo-Controlled Trial in Patients with Retinitis Pigmentosa
StatusActive
Effective start/end date3/17/227/31/24

Funding

  • JOHNS HOPKINS UNIVERSITY
  • NATIONAL INSTITUTES OF HEALTH (NIH)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.